申请人:Purdue Pharma L.P.
公开号:US20150133500A1
公开(公告)日:2015-05-14
The invention provides compounds that are useful as sodium channel blockers. In one aspect, the invention provides compounds of Formula I:
and pharmaceutically acceptable salts, solvates, hydrates, or diastereomers thereof, wherein W
1
, W
2
, W
3
, W
4
, U, G, m, R
1
, and R
2
are defined in the disclosure. In certain embodiments, the invention provides compounds of Formulae II to V as set forth supra. The invention also provides the use of compounds of any of the above discussed formulae to treat a disorder responsive to blockade of sodium channels. In one embodiment, Compounds of the Invention are useful for treating pain.
该发明提供了作为钠通道阻滞剂有用的化合物。在一个方面,该发明提供了公式I的化合物:以及其药用可接受的盐、溶剂化合物、水合物或对映体,其中W1、W2、W3、W4、U、G、m、R1和R2在公开中有定义。在某些实施例中,该发明提供了如上所述的公式II至V的化合物。该发明还提供了利用上述讨论的任何公式的化合物来治疗对钠通道阻滞反应的疾病。在一个实施例中,该发明的化合物可用于治疗疼痛。